Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
暂无分享，去创建一个
D. Levine | D. Mutch | A. Secord | K. Thiel | E. Devor | K. Leslie | C. Aghajanian | H. Lankes | K. Moxley | P. Rose | V. Filiaci | C. Mathews | K. Tewari | M. Mcdonald | A. Mallen | Y. Casablanca | D. Richardson | Kristina W. Thiel | S. Dewdney | M. McHale | C. Cosgrove | X. Zhou | A. Jackson